Live Analyst Rating Changes 54325 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Joanne Wuensch
Citi

Joanne Wuensch

Citi
Wall Street Analyst
★★★★★
#205
on 13Foresight · ranked by our own returns
64%
Success Rate
+3.8%
Average Return
107 of 167 calls profitable · +2.6% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 64% of Joanne Wuensch's ratings turned a profit when each position was held for 1 year — averaging +3.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

159 Buy 101 Hold 4 Sell
Joanne's Stock Coverage 32 ratings · 2026-11-06
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
SYK
Stryker
 Oct 30, 2026 BUY Strong Buy
+18.5% avg upside
38 analysts
$315.00
7.95% Upside
 +16.3% ·
WST
West Pharmaceutical Services
 Oct 30, 2026 BUY Strong Buy
-6.0% avg upside
18 analysts
$494.00
19.65% Upside
 -1.4% ·
BSX
Boston Scientific
 Oct 29, 2026 HOLD Strong Buy
+43.0% avg upside
38 analysts
$44.00
4.82% Upside
 +7.3% ·
BLCO
Bausch + Lomb Corporation
 Oct 29, 2026 BUY Buy
+7.5% avg upside
20 analysts
$23.00
14.99% Upside
 -2.4% ·
GKOS
Glaukos
 Oct 29, 2026 BUY Strong Buy
-18.6% avg upside
21 analysts
$247.00
3.87% Upside
 -9.3% ·
GEHC
GE Healthcare Technologies Inc
 Oct 29, 2026 HOLD Strong Buy
+10.2% avg upside
23 analysts
$79.00
3.09% Upside
 +7.8% ·
IART
Integra Lifesciences
 Oct 22, 2026 HOLD Buy
+208.1% avg upside
22 analysts
$14.00
9.86% Upside
 +3.4% ·
ABT
Abbott Laboratories
 Oct 22, 2026 BUY Strong Buy
+8.5% avg upside
36 analysts
$122.00
14.97% Upside
 +7.5% ·
TNDM
Tandem Diabetes Care
 Oct 21, 2026 HOLD Buy
+64.3% avg upside
29 analysts
$20.00
4.75% Upside
 +11.1% ·
DXCM
Dexcom
 Oct 21, 2026 BUY Strong Buy
+31.4% avg upside
33 analysts
$105.00
27.57% Upside
 +0.9% ·
MMED
MiniMed Group, Inc.
 Oct 21, 2026 BUY Strong Buy
+37.6% avg upside
17 analysts
$26.00
42.33% Upside
 +2.7% ·
EW
Edwards Lifesciences
 Oct 21, 2026 BUY Strong Buy
+10.0% avg upside
35 analysts
$110.00
19.49% Upside
 +14.6% ·
PODD
Insulet
 Oct 21, 2026 HOLD Strong Buy
+40.0% avg upside
32 analysts
$150.00
0.23% Upside
 +16.3% ·
ISRG
Intuitive Surgical
 Oct 20, 2026 BUY Strong Buy
+12.0% avg upside
37 analysts
$500.00
15.66% Upside
 +3.4% ·
PEN
Penumbra
 Oct 05, 2026 HOLD Buy
+3.6% avg upside
23 analysts
$350.00
9.69% Upside
 +0.9% ·
BAX
Baxter International
 Oct 05, 2026 HOLD Buy
+45.2% avg upside
23 analysts
$27.00
17.31% Upside
 +5.2% ·
BDX
Becton Dickinson
 Oct 05, 2026 BUY Buy
-0.4% avg upside
25 analysts
$208.00
5.05% Upside
 +15.8% ·
JNJ
Johnson & Johnson
 Oct 05, 2026 BUY Strong Buy
-9.1% avg upside
40 analysts
$303.00
10.94% Upside
 +8.9% ·
MDT
Medtronic
 Oct 05, 2026 BUY Buy
+4.4% avg upside
38 analysts
$110.00
13.99% Upside
 +19.2% ·
ZBH
Zimmer Biomet Holdings
 Oct 05, 2026 HOLD Buy
+20.5% avg upside
39 analysts
$99.00
4.64% Upside
 +15.3% ·
SGHT
Sight Sciences
 Oct 05, 2026 HOLD Buy
+9.7% avg upside
14 analysts
$10.00
7.24% Upside
 +5.6% ·
COO
Cooper Co
 Oct 02, 2026 HOLD Buy
+105.8% avg upside
21 analysts
$60.00
0.79% Upside
 +11.6% ·
DHR
Danaher
 Sep 21, 2026 BUY Strong Buy
-4.4% avg upside
47 analysts
$230.00
0.90% Downside
 +6.8% ·
HAE
Haemonetics
 Sep 18, 2026 BUY Strong Buy
-20.9% avg upside
18 analysts
$123.00
2.72% Upside
 +10.4% ·
ESTA
Establishment Labs Holdings
 Aug 13, 2026 BUY Strong Buy
+45.5% avg upside
13 analysts
$92.00
47.33% Upside
 -11.3% ·
IRTC
Irhythm Technologies
 Aug 13, 2026 BUY Strong Buy
+32.2% avg upside
21 analysts
$157.00
27.17% Upside
 +2.6% ·
WAT
Waters
 Aug 10, 2026 BUY Strong Buy
-12.6% avg upside
31 analysts
$470.00
1.64% Upside
 +11.6% ·
ITGR
Integer Holdings
 Jul 08, 2026 HOLD Buy
-18.9% avg upside
16 analysts
$96.00
24.21% Downside
 +38.9% ·
LUNG
Pulmonx
 May 23, 2025 HOLD Buy
+152.1% avg upside
9 analysts
$4.15
38.03% Upside
 -50.2% ·
CH:ALC
Alcon
 Nov 16, 2022 HOLD Strong Buy
+19.4% avg upside
36 analysts
$56.63
4.13% Downside
 +1.5% ·
RMD
Resmed
 Jan 27, 2019 BUY Buy
+4.7% avg upside
27 analysts
$120.00
47.75% Downside
 +77.7% ·
PFE
Pfizer
 Sep 26, 2016 BUY Buy
+9.2% avg upside
46 analysts
$40.00
31.08% Upside
 +9.2% ·
🔒 27 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Joanne Wuensch — Frequently Asked Questions
How accurate are Joanne Wuensch's stock ratings?
Based on the calls 13Foresight could measure, about 64% of Joanne's ratings were profitable over a one-year hold, with an average return of +3.8% per rating, or +2.6% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Joanne ranked on 13Foresight?
Joanne Wuensch is currently ranked #205 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Joanne cover?
Joanne most recently has ratings on SYK, WST, BSX, BLCO, GKOS, GEHC, IART, ABT, TNDM, DXCM, MMED, EW and 20 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.